This marks the second FDA-approved agent for the condition, and the first IL-17A inhibitor.
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
The development, which was announced today, makes secukinumab the first and only interleukin -17A inhibitor approved by the FDA for HS, which affects an estimated 1% of the worldwide population. It joins theevaluated efficacy, safety, and tolerability of two dose regimens of the drug in adults with moderate-to-severe HS at 16 weeks and up to 52 weeks.
Please use this form to submit your questions or comments on how to make this article more useful to clinicians.use this form to submit personal or patient medical information or to report adverse drug events. You are encouraged to report adverse drug event information to the FDA.All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drugU.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
Lire la suite »
Heat-related heart deaths projected to increase in the US, especially among seniors and Black adults(CNN) — Extreme heat can take a heavy toll on the heart, and a new report shows how much more deadly the effects of climate change may become over the next few decades in the United States. Black adults, seniors and people living in urban areas are particularly vulnerable. Between 2008 and 2019, the heat index...
Lire la suite »
Tips on staying safe during Halloween for kids and adultsSave the spooky stuff for the festivities! Do your part to look out for each other on and off the roads in North Texas this week.
Lire la suite »
Depression and anxiety may impact young adults twice as much as teens, Harvard survey findsA new report from Harvard reveals the rising rates of depression and anxiety among young adults. Experts shared potential reasons and strategies that could help.
Lire la suite »
Just 7% of U.S. Adults Have Gotten Updated COVID VaccineFewer Americans are rolling up their sleeves for the updated COVID-19 shot, leading health experts to call for a stepped-up vaccination campaign.
Lire la suite »